Pharmacokinetics and pharmacodynamics of dexmedetomidine

References

• Paris A, Tonner PH. Dexmedetomidine in anaesthesia. Curr Opin Anaesthesiol 2005;18:412–18.
   PubMed Web of Science ®Google Scholar
• Tobias. Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med 2007;8:115–31.
   PubMed Web of Science ®Google Scholar
• Bischoff Kochs Alpha-2 agonists in anesthesia and intensive medicine. Anasthesiol, Intensivmed, Notfallmed, Schmerzther 1993;28:2–12.
   PubMedGoogle Scholar
• Grasshoff C, Drexler B, Rudolph U, Antkowiak B. Anesthetic drugs: Linking molecular actions to clinical effects. Curr Pharm Des 2006;12:3665–79.
   PubMed Web of Science ®Google Scholar
• Lawrence CJ, De Lange S. Effects of a single pre-operative dexmedetomidine dose on isoflurane requirements and peri-operative haemodynamic stability. Anaesthesia 1997;52:736–45.
   PubMed Web of Science ®Google Scholar
• Aho M, Lehtinen AM, Erkola O, et al. Dexmedetomidine may reduce isoflurane requirements during abdominal hysterectomy. Anesth Analg 1990;70:S5.
   Google Scholar
• Aho M, Lehtinen AM, Erkola, et al. The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology 1991;74:997–1002.
   PubMed Web of Science ®Google Scholar
• Peden CJ, Cloote AH, Stratford N et al. The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil. Anesthesia 2001;56:408–13.
   PubMed Web of Science ®Google Scholar
• Aantaa R, Kanto J, Scheinin M, et al. Dexmedetomidine premedication for minor gynecologic surgery. Anesth. Analg 1990;70:407–13.
   PubMed Web of Science ®Google Scholar
• Aantaa R, Jaakola ML, Kallio A, et al. Comparison of dexmedetomidine, an alpha2-adrenoceptor agonist, and midazolam as im premedication for minor gynaecological surgery. Br J Anesth 1991;67:402–9.
   PubMed Web of Science ®Google Scholar
• Jaakola ML, Ali-Melkkilä T, Kanto J, et al. Dexmedetomidine reduces intraocular pressure, intubation responses and anaesthetic requirements in patients undergoing ophthalmic surgery. Br J Anaesth 1992;68:570–5.
   PubMed Web of Science ®Google Scholar
• Bührer M, Mappes A, Lauber R, et al. Dexmedetomidine decreases thiopental dose requirement and alters distribution pharmacokinetics. Anesthesiology 1994;80:1216–27.
   PubMed Web of Science ®Google Scholar
• Scheinin H, Jaakola ML, Sjövall S, et al. Intramuscular dexmedetomidine as premedication for general anesthesia. A comparative multicenter study. Anesthesiology 1993;78:1065–75.
   PubMed Web of Science ®Google Scholar
• Unlugenc H, Gunduz M, Guler T, et al. The effect of pre-anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient-controlled morphine. Eur J Anaesthesiol 2005;22:386–91.
   PubMed Web of Science ®Google Scholar
• Aantaa R, Kanto J, Scheinin M. Intramuscular dexmedetomidine, a novel alpha2‐adrenoceptor agonist, as premedication for minor gynaecological surgery. Acta Anaesthesiol Scand 1991;35:283–8.
   PubMed Web of Science ®Google Scholar
• Aho M, Schenin M, Lehtinen AM, et al. Intramuscularly administered dexmedetomidine attenuates hemodynamic and stress hormone responses to gynecologic laparoscopy. Anesth Analg 1992;75:932939.
   Google Scholar
• Levanen J, Makela M, Scheinin H. Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium. J Am Soc Anesthesiol 1995;82:1117–25.
   PubMed Web of Science ®Google Scholar
• Zub D, Berkenbosch JW, Tobias JD. Preliminary experience with oral dexmedetomidine for procedural and anesthetic premedication. Pediatr Anesth 2005;15:932–8.
   PubMed Web of Science ®Google Scholar
• Yuen VM, Hui TW, Irwin MG, Yuen MK. A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded randomized controlled trial. Anesth Analg 2008;106:1715–21.
   PubMed Web of Science ®Google Scholar
• Guler G, Akin A, Tosun Z, et al. Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation. Acta Anaesthesiol Scand 2005;49:1088–91.
   PubMed Web of Science ®Google Scholar
• Jaionen J, Hynynen M, Kuitunen A, et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. J Am Soc Anesthesiol 1997;86:331–45.
   PubMed Web of Science ®Google Scholar
• Sturaitis M, Kroin J, Swamidoss C, Moric M. Effects of intraoperative dexmedetomidine infusion on hemodynamic stability during brain tumor resection. Anesthesiology 2002;97:A310.
   Google Scholar
• Talke P, Chen R, Thomas B, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg 2000;90:834–9.
   PubMed Web of Science ®Google Scholar
• Nichols DP, Berkenbosch JW, Tobias JD. Rescue sedation with dexmedetomidine for diagnostic imaging: a preliminary report. Paediatr Anaesth 2005;15:199–203.
   PubMed Web of Science ®Google Scholar
• Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000;4:302.
   PubMed Web of Science ®Google Scholar
• Alhashemi JA, Kaki AM. Dexmedetomidine in combination with morphine PCA provides superior analgesia for shockwave lithotripsy. Can J Anaesth 2004;51:342–7.
   PubMed Web of Science ®Google Scholar
• Jorden VS, Pousman RM, Sanford MM, et al. Dexmedetomidine overdose in the perioperative setting. Ann Pharmacother 2004;38:803–7.
   PubMed Web of Science ®Google Scholar
• Ickeringill M, Shehabi Y, Adamson H, Ruettimann U. Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation: haemodynamic effects and efficacy. Anaesth Intensive Care 2004;32:741.
   PubMed Web of Science ®Google Scholar
• Ramsay M, Jones C, Cancemi M, et al. Dexmedetomidine improves postoperative pain management in bariatric surgical patients. Anesthesiology 2002;96:A910.
   Google Scholar
• Martin E, Ramsay G, Mantz J, Sum-Ping ST. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 2003;18:29–41.
   PubMedGoogle Scholar
• Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999;54:1136–42.
   PubMed Web of Science ®Google Scholar
• Venn M, Newman J, Grounds M. A phase ii study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med 2003;29:201–7.
   PubMed Web of Science ®Google Scholar
• Venn RM Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anesth 2001;87:684–90.
   PubMed Web of Science ®Google Scholar
• Elbaradie S, El Mahalawy FH, Solyman AH. Dexmedetomidine vs. Propofol for short-term sedation of postoperative mechanically ventilated patients. J Egypt Natl Canc Inst 2004;16:153–8.
   PubMedGoogle Scholar
• Takrouri MS, Seraj MA, Channa AB, et al. Dexmedetomidine in intensive care unit: A study of hemodynamic changes. Middle East J Anaesthesiol 2002;16:587–95.
   PubMedGoogle Scholar
• Doufas AG, Lin CM, Suleman MI, et al. Dexmedetomidine and meperidine additively reduce the shivering threshold in humans. Stroke 2003;34:1218–23.
   PubMed Web of Science ®Google Scholar
• Maroof M, Khan SA, Jain D, et al. Evaluation of effect of dexmedetomidine in reducing shivering following epidural anesthesia. Anesthesiology 2004;101:A495.
   PubMed Web of Science ®Google Scholar
• Multz AS. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg 2003;96:1054–5.
   PubMed Web of Science ®Google Scholar
• Maccioli GA. Dexmedetomidine to facilitate drug withdrawal. J Am Soc Anesthesiol 2003;98:575–7.
   PubMed Web of Science ®Google Scholar
• Baddigam K, Russo P, Russo J, Tobias JD. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients. J Intensive Care Med 2005;20:118–23.
   PubMedGoogle Scholar
• Jaakola ML. Dexmedetomidine premedication before intravenous regional anesthesia in minor outpatient hand surgery. J Clin Anesth 1994;6:204–11.
   PubMed Web of Science ®Google Scholar
• Jalowiecki P, Rudner R, Gonciarz M, et al. Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy. J Am Soc Anesthesiol 2005;103:269–73.
   PubMed Web of Science ®Google Scholar
• Virkkilä M, Ali‐Melkkilä T, Kanto J, et al. Dexmedetomidine as intramuscular premedication in outpatient cataract surgery. A placebo-controlled dose-ranging study. Anesthesia 1993;48:482–7.
   PubMed Web of Science ®Google Scholar
• Doze V, Chen BX, Li Z, Maze M. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine. Acta Vet Scand Suppl 1988;85:61–4.
   Google Scholar
• Doze VA, Chen BX, Maze M. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors. Anesthesiology 1989;71:75–9.
   PubMed Web of Science ®Google Scholar
• Weinger MB, Segal IS, Maze M. Dexmedetomidine, acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity in the rat. Anesthesiology 1989;71:242–9.
   PubMed Web of Science ®Google Scholar
• Guo TZ, Jiang JY, Buttermann AE, Maze M. Dexmedetomidine injection into the locus ceruleus produces antinociception. J Am Soc Anesthesiol 1996;84:873–81.
   PubMed Web of Science ®Google Scholar
• Correa-Sales C, Rabin BC, Maze M. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology 1992;76:948–52.
   PubMed Web of Science ®Google Scholar
• Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent) 2001;14:13.
   PubMedGoogle Scholar
• Gupta K, Tiwari V, Gupta PK, et al. Prolongation of subarachnoid block by intravenous dexmedetomidine for sub umbilical surgical procedures: a prospective control study. Anesth Essays Res 2014;8:175.
   PubMedGoogle Scholar
• Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382–94.
   PubMed Web of Science ®Google Scholar
• Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother 2007;41:245–54.
   PubMed Web of Science ®Google Scholar
• Riquelme JA, Westermeier F, Hall AR, et al. Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial enos/no dependent mechanism. Pharmacol Res 2016;103:318–27.
   PubMed Web of Science ®Google Scholar
• Maier C, Steinberg GK, Sun GH, et al. Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology 1993;79:306–12.
   PubMed Web of Science ®Google Scholar
• Holliday SF, Kane-Gill SL, Empey PE, et al. Interpatient variability in dexmedetomidine response: a survey of the literature. ScientificWorldJournal 2014;2014:805013.
   PubMed Web of Science ®Google Scholar
• Shehabi Y, Botha JA, Ernest D, et al. Clinical application, the use of dexmedetomidine in intensive care sedation. Depression 2010;16:17.
   Google Scholar
• Kohli U, Pandharipande P, Muszkat M, et al. Cyp2a6 genetic variation and dexmedetomidine disposition. Eur J Clin Pharmacol 2012;68:937–42.
   PubMed Web of Science ®Google Scholar
• Cortínez LI, Anderson BJ, Holford NH, et al. Dexmedetomidine pharmacokinetics in the obese. Eur J Clin Pharmacol 2015;71:1501–8.
   PubMed Web of Science ®Google Scholar
• Potts AL, Warman GR, Anderson BJ. Dexmedetomidine disposition in children: A population analysis. Pediatr Anesth 2008;18:722–30.
   PubMed Web of Science ®Google Scholar
• Assessment report: Dexdor. London, United Kingdom: European Medicines Agency; 2011.
   Google Scholar
• Iirola T, Aantaa R, Laitio R, et al. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients. Crit Care 2011;15:R257.
   PubMed Web of Science ®Google Scholar
• Karol M, Maze M. Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humans. Best Pract Res Clin Anesthesiol 2000;14:261–9.
   Google Scholar
• Anttila M, Penttilä J, Helminen A, et al. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol 2003;56:691–3.
   PubMed Web of Science ®Google Scholar
• Hospira Inc. Precedex™ prescribing information. Lake Forest, IL: Hospira Inc; 2015.
   Google Scholar
• Lee S, Kim BH, Lim K, et al. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects. J Clin Pharm Ther 2012;37:698–703.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang Z, Wu L, et al. Determination of dexmedetomidine in human plasma using high performance liquid chromatography coupled with tandem mass spectrometric detection: Application to a pharmacokinetic study. J Pharm Biomed Anal 2009;50:897–904.
   PubMed Web of Science ®Google Scholar
• Iirola T, Vilo S, Manner T, et al. Bioavailability of dexmedetomidine after intranasal administration. Eur J Clin Pharmacol 2011;67:825–31.
   PubMed Web of Science ®Google Scholar
• Vilo S, Iirola T, Kurvinen JP, et al. Bioavailability of dexmedetomidine after intranasal administration in healthy subjects. Eur J Anesthesiol 2010;27:152–4.
   Google Scholar
• Scheinin H, Karhuvaara S, Olkkola KT, et al. Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine. Clin Pharmacol Ther 1992;52:537–46.
   PubMed Web of Science ®Google Scholar
• Dyck JB, Maze M, Haack C, et al. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993;78:813–20.
   PubMed Web of Science ®Google Scholar
• Ette EI, Williams PJ. Population pharmacokinetics I: background, concepts, and models. Ann Pharmacother 2004;38:1702–6.
   PubMed Web of Science ®Google Scholar
• Petroz GC, Sikich N, James M, et al. A phase i, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. J Am Soc Anesthesiol 2006;105:1098–110.
   PubMed Web of Science ®Google Scholar
• Su F, Nicolson SC, Gastonguay MR, et al. The population pharmacokinetics of dexmedetomidine in infants after open heart surgery. Anesth Analg 2010;110:1383.
   PubMed Web of Science ®Google Scholar
• Vilo S, Rautiainen P, Kaisti K, et al. Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age. Br J Anaesth 2008;100:697–700.
   PubMed Web of Science ®Google Scholar
• Hannivoort LN, Eleveld DJ, Proost JH, et al. Development of an optimized pharmacokinetic model of dexmedetomidine using target-controlled infusion in healthy volunteers. J Am Soc Anesthesiol 2015;123:357–67.
   PubMed Web of Science ®Google Scholar
• Dyck JB, Maze M, Haack C, et al. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993;78:821–8.
   PubMed Web of Science ®Google Scholar
• Iirola T, Ihmsen H, Laitio R, et al. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients. Br J Anesth 2012;108:460–8.
   PubMed Web of Science ®Google Scholar
• Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anesth 2002;88:669–75.
   PubMed Web of Science ®Google Scholar
• Talke P, Richardson CA, Scheinin M, Fisher DM. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 1997;85:1136–42.
   PubMed Web of Science ®Google Scholar
• De Wolf AM, Fragen RJ, Avram MJ, et al. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg 2001;93:1205–9.
   PubMed Web of Science ®Google Scholar
• Dutta S, Lal R, Karol MD, et al. Influence of cardiac output on dexmedetomidine pharmacokinetics. J Pharm Sci 2000;89:519–27.
   PubMed Web of Science ®Google Scholar
• Lin L, Guo X, Zhang MZ, et al. Pharmacokinetics of dexmedetomidine in Chinese post-surgical intensive care unit patients. Acta Anaesthesiol Scand 2011;55:359–67.
   PubMed Web of Science ®Google Scholar
• Scheinin H, Aantaa R, Anttila M, et al. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific α2-adrenoceptor antagonist atipamezolea pharmacodynamic and kinetic study in healthy volunteers. J Am Soc Anesthesiol 1998;89:574–84.
   PubMed Web of Science ®Google Scholar
• Lawrence CJ, Prinzen FW, de Lange S. The effect of dexmedetomidine on nutrient organ blood flow. Anesth Analg 1996;83:1160–5.
   PubMed Web of Science ®Google Scholar
• Talke PO, Caldwell JE, Richardson CA, et al. The effects of dexmedetomidine on neuromuscular blockade in human volunteers. Anesth Analg 1999;88:633–9.
   PubMed Web of Science ®Google Scholar
• Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. Ii. Hemodynamic changes. Anesthesiology 1992;77:1134–42.
   PubMed Web of Science ®Google Scholar
• Bekker AY, Kaufman B, Samir H, Doyle W. The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg 2001;92:1251–3.
   PubMed Web of Science ®Google Scholar
• Angst MS, Ramaswamy B, Davies MF, Maze M. Comparative analgesic and mental effects of increasing plasma concentrations of dexmedetomidine and alfentanil in humans. J Am Soc Anesthesiol 2004;101:744–52.
   PubMed Web of Science ®Google Scholar
• Hsu YW, Cortinez LI, Robertson KM, et al. Dexmedetomidine pharmacodynamics: Part icrossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. J Am Soc Anesthesiol 2004;101:1066–76.
   PubMed Web of Science ®Google Scholar
• Koroglu A, Demirbilek S, Teksan O, et al. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: Preliminary results. Br J Anaesth 2005;94:821–4.
   PubMed Web of Science ®Google Scholar
• Mukhtar AM, Obayah EM, Hassona AM. The use of dexmedetomidine in pediatric cardiac surgery. Anesth Analg 2006;103:52–6.
   PubMed Web of Science ®Google Scholar
• Tobias JD, Berkenbosch JW. Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth 2002;12:171–5.
   PubMed Web of Science ®Google Scholar
• Tobias. Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU. J Opioid Manag 2005;2:201–5.
   Google Scholar
• Talke P, Tayefeh F, Sessler DI, et al. Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds. Anesthesiology 1997;87:835–41.
   PubMed Web of Science ®Google Scholar
• Aantaa R, Kanto J, Scheinin M, et al. Dexmedetomidine, an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology 1990;73:230–5.
   PubMed Web of Science ®Google Scholar
• Prielipp RC, Wall MH, Tobin JR, et al. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg 2002;95:1052–9.
   PubMed Web of Science ®Google Scholar
• Talke P, Tong C, Lee HW, et al. Effect of dexmedetomidine on lumbar cerebrospinal fluid pressure in humans. Anesth Analg 1997;85:358–64.
   PubMed Web of Science ®Google Scholar
• Shehabi Y, Ruettimann U, Adamson H, et al. Dexmedetomidine infusion for more than 24 hours in critically ill patients: Sedative and cardiovascular effects. Intensive Care Med 2004;30:2188–96.
   PubMed Web of Science ®Google Scholar
• Mason KP, Zurakowski D, Zgleszewski SE, et al. High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth 2008;18:403–11.
   PubMed Web of Science ®Google Scholar
• Berkenbosch JW, Wankum PC, Tobias JD. Prospective evaluation of dexmedetomidine for noninvasive procedural sedation in children*. Pediatr Crit Care Med 2005;6:435–9.
   PubMedGoogle Scholar
• Lam MA, Bhatia SK, Lee LA, et al. Influence of dexmedetomidine on co2 reactivity and cerebral autoregulation in healthy volunteers. Anesthesiology 2001;95:A341.
   Google Scholar
• Prielipp RC, Wall MH, Tobin JR, et al. Dexmedetomidine infusion decreases cerebral blood flow in humans. Anesth Analg 1994;79:892–8.
   PubMed Web of Science ®Google Scholar
• Yoo H, Iirola T, Vilo S, et al. Mechanism-based population pharmacokinetic and pharmacodynamic modeling of intravenous and intranasal dexmedetomidine in healthy subjects. Eur J Clin Pharmacol 2015;71:1197–207.
   PubMed Web of Science ®Google Scholar